Harvard Bioscience Inc
NASDAQ:HBIO
Harvard Bioscience Inc
Net Income (Common)
Harvard Bioscience Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Harvard Bioscience Inc
NASDAQ:HBIO
|
Net Income (Common)
-$3.4m
|
CAGR 3-Years
24%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-6%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Net Income (Common)
$6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
Danaher Corp
NYSE:DHR
|
Net Income (Common)
$8.1B
|
CAGR 3-Years
21%
|
CAGR 5-Years
27%
|
CAGR 10-Years
12%
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Net Income (Common)
$568.7m
|
CAGR 3-Years
10%
|
CAGR 5-Years
21%
|
CAGR 10-Years
18%
|
|
Agilent Technologies Inc
NYSE:A
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Net Income (Common)
$1.4B
|
CAGR 3-Years
69%
|
CAGR 5-Years
39%
|
CAGR 10-Years
20%
|
See Also
What is Harvard Bioscience Inc's Net Income (Common)?
Net Income (Common)
-3.4m
USD
Based on the financial report for Dec 31, 2023, Harvard Bioscience Inc's Net Income (Common) amounts to -3.4m USD.
What is Harvard Bioscience Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-6%
Over the last year, the Net Income (Common) growth was 64%. The average annual Net Income (Common) growth rates for Harvard Bioscience Inc have been 24% over the past three years , -3% over the past five years , and -6% over the past ten years .